Last reviewed · How we verify

thyrotropin-releasing hormone

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Phase 3 active Small molecule

Thyrotropin-releasing hormone stimulates the release of thyroid-stimulating hormone (TSH) from the anterior pituitary gland.

Thyrotropin-releasing hormone stimulates the release of thyroid-stimulating hormone (TSH) from the anterior pituitary gland. Used for Hypothyroidism due to insufficient TSH production, Diagnostic testing of pituitary function.

At a glance

Generic namethyrotropin-releasing hormone
SponsorEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Drug classhormone
TargetTRH receptor
ModalitySmall molecule
Therapeutic areaEndocrinology
PhasePhase 3

Mechanism of action

TRH acts on the thyrotroph cells in the anterior pituitary gland by binding to its G-protein coupled receptors, leading to increased intracellular calcium levels and subsequent secretion of TSH, which then regulates thyroid hormone production.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results